Narcolepsy
Not yet recruitingStudy on TAK-861 for Treating Narcolepsy with Cataplexy in Patients
Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients
- Disease:Narcolepsy
- Substances:–
Austria- Participants:18–64 years · 65+ years
Rare diseases
Investigational molecules
Locations
Study on TAK-861 for Treating Narcolepsy with Cataplexy in Patients
AustriaStudy on the Safety of Argon and Oxygen Ventilation for Patients Resuscitated from Cardiac Arrest
ItalyStudy on the Effectiveness of Floxuridine in Patients with Resectable Colorectal Liver Metastases and Low Clinical Risk Score
The NetherlandsStudy on Ketamine for Treating Patients with Severe Brain Injury and Disorders of Consciousness
BelgiumStudy on Fluconazole and Cefalexin Monohydrate for Treating Laryngeal Leukoplakia in Adults
FinlandStudy on the Tolerability and Acceptance of Oral Hydrocortisone for Children with Adrenal Hyperplasia or Adrenal Insufficiency
SpainA Study of High-Concentration Oxygen Treatment in Patients with Heart Failure, Pulmonary Hypertension, and Coronary Microvascular Dysfunction
The NetherlandsStudy on the Safety and Tolerability of INP20 for Peanut Allergy in Patients
SpainStudy on the Effects of Botulinum Toxin A for Improving Arm Function in Patients with Chronic Stroke
FranceStudy of Bemarituzumab with Irinotecan, Paclitaxel, Ramucirumab, or Trifluridine/Tipiracil for Advanced Stomach or Gastroesophageal Cancer in Patients After Chemotherapy
GermanyStudy on Using Nicotine Electronic Cigarettes and Varenicline for Smoking Cessation in Smokers of 10+ Cigarettes Daily
FranceStudy on Gene Therapy for Patients with RAG1-Deficient Severe Combined Immunodeficiency Using RAG1-LV-CD34+ Cells
ItalyTell us about your condition – we search every trial in Europe and connect you with the right site.